High-Dose Vitamin B12 Does Not Contribute to Restless Legs Syndrome
There is no evidence that high-dose vitamin B12 (cyanocobalamin or methylcobalamin) causes or contributes to restless legs syndrome (RLS). In fact, the available evidence suggests the opposite relationship: vitamin B12 deficiency may be associated with RLS, not excess.
Evidence Against B12 Causing RLS
The most recent and comprehensive guideline on RLS treatment from the American Academy of Sleep Medicine (2025) makes no mention of vitamin B12 supplementation as a cause or contributor to RLS 1. This guideline extensively reviewed treatments and risk factors for RLS, and vitamin B12 excess was not identified as a concern.
Research Findings on B12 and RLS
Multiple recent studies demonstrate an inverse relationship between vitamin B12 levels and RLS:
Lower B12 levels are associated with RLS presence: A 2022 study found that RLS patients had significantly reduced serum vitamin B12 levels compared to controls, and multivariate analysis showed B12 deficiency was independently associated with RLS development (OR=0.97,95% CI: 0.96-0.98) 2. Lower B12 levels correlated negatively with symptom severity scores.
B12 deficiency predicts RLS in specific populations: In adolescents, lower vitamin B12 levels were associated with higher RLS frequency, and patients with insufficient B12 had statistically higher prevalence of RLS 3. Similarly, in IBD patients, vitamin B12 deficiency was the only factor associated with RLS diagnosis (OR=10.20,95% CI=1.40-74.10) 4.
No association between B12 supplementation and RLS: A 2008 study examining B vitamin status in 228 subjects (including 97 RLS patients) found no significant differences in B12 levels between RLS patients and controls, and no relationship between B12 status and RLS 5.
Safety Profile of High-Dose B12
The FDA drug label for methylcobalamin notes specific warnings about aluminum toxicity in parenteral formulations, benzyl alcohol in certain preparations, and risks in patients with Leber's disease 6. Restless legs syndrome is not listed as an adverse effect or warning in the official prescribing information.
Clinical Implications
When evaluating a patient with RLS:
- Check vitamin B12 levels as part of the workup, particularly in patients with risk factors for deficiency (vegetarian diet, malabsorption, pregnancy, certain medications)
- Do not discontinue B12 supplementation if a patient develops RLS symptoms—the B12 is not the cause
- Focus on established RLS risk factors and treatments per the 2025 AASM guidelines, which prioritize iron status assessment (ferritin and transferrin saturation), α2δ calcium channel ligands (gabapentin, pregabalin), and IV iron therapy for appropriate candidates 1, 7, 8
Common Pitfall to Avoid
Do not confuse the association between B12 deficiency and RLS with causation from B12 supplementation. The evidence consistently points to low B12 as a potential contributor to RLS, not high B12.